71 related articles for article (PubMed ID: 13435494)
1. Prophylactic oophorectomy in treatment of cancer of the breast.
HORSLEY GW
Am Surg; 1957 Apr; 23(4):396-8. PubMed ID: 13435494
[No Abstract] [Full Text] [Related]
2. Adrenalectomy-oophorectomy in advanced breast cancer.
SAIKKU LA; VANKKA EA
Ann Chir Gynaecol Fenn; 1960; 49():364-70. PubMed ID: 13745422
[No Abstract] [Full Text] [Related]
3. [Breast neoplasms. Result of combined treatment: extended Halstead operation with and without bilateral oophorectomy in one stage].
POLETTO E; AUDENINO RG
Dia Med; 1961 Jul; 33():1275-7. PubMed ID: 13736715
[No Abstract] [Full Text] [Related]
4. Laparoscopic oophorectomy in the management of breast disease.
Willsher P; Ali A; Jackson L
ANZ J Surg; 2008 Aug; 78(8):670-2. PubMed ID: 18796025
[TBL] [Abstract][Full Text] [Related]
5. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
6. TOTAL HYSTERECTOMY COMBINED WITH PROPHYLACTIC BILATERAL OOPHORECTOMY IN TREATMENT OF BREAST CANCER.
VARDEN LC; RICHTMEYER DC
Va Med Mon (1918); 1963 Oct; 90():501-4. PubMed ID: 14069382
[No Abstract] [Full Text] [Related]
7. Bilateral adrenalectomy and oophorectomy in the treatment of recurrent carcinoma of the breast.
EDDY JP
R I Med J; 1955 Apr; 38(4):207-9. PubMed ID: 14372764
[No Abstract] [Full Text] [Related]
8. [Palliative treatment of metastatic cancer of the breast by total ovariectomy and adrenalectomy in two stages; indications furnished by the study of calcic metabolism].
SMETS W; DOR P; KENIS Y; TAGNON H
Rev Fr Etud Clin Biol; 1957 Jun; 2(6):566-78. PubMed ID: 13454102
[No Abstract] [Full Text] [Related]
9. The effect of adrenalectomy and oophorectomy in the treatment of far advanced carcinoma of the breast.
ROE WF; BERNE CJ
West J Surg Obstet Gynecol; 1954 Sep; 62(9):457-61. PubMed ID: 13196310
[No Abstract] [Full Text] [Related]
10. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
11. Treatment of cancer of the breast.
Fraser J
Practitioner; 1969 Aug; 203(214):146-52. PubMed ID: 5803923
[No Abstract] [Full Text] [Related]
12. [Endocrino-surgical treatment of mammary cancer in the disseminated stage].
Ruggeri F; Jacobelli G; Grechi G
Cancro; 1966; 19(4):313-8. PubMed ID: 5989573
[No Abstract] [Full Text] [Related]
13. What is the role of ovarian ablation in the management of primary and metastatic breast cancer today?
Prowell TM; Davidson NE
Oncologist; 2004; 9(5):507-17. PubMed ID: 15477635
[TBL] [Abstract][Full Text] [Related]
14. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
Metcalfe KA; Lubinski J; Ghadirian P; Lynch H; Kim-Sing C; Friedman E; Foulkes WD; Domchek S; Ainsworth P; Isaacs C; Tung N; Gronwald J; Cummings S; Wagner T; Manoukian S; Møller P; Weitzel J; Sun P; Narod SA;
J Clin Oncol; 2008 Mar; 26(7):1093-7. PubMed ID: 18195327
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic oophorectomy in women at increased cancer risk.
Domchek SM; Rebbeck TR
Curr Opin Obstet Gynecol; 2007 Feb; 19(1):27-30. PubMed ID: 17218848
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic oophorectomy for breast carcinoma.
Med J Aust; 1971 Apr; 1(17):884. PubMed ID: 5576801
[No Abstract] [Full Text] [Related]
17. Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomized trial.
Groenvold M; Fayers PM; Petersen MA; Mouridsen HT
Breast Cancer Res Treat; 2006 Aug; 98(3):275-84. PubMed ID: 16541325
[TBL] [Abstract][Full Text] [Related]
18. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
[TBL] [Abstract][Full Text] [Related]
19. [The role and place of the prophilactic oophorectomy].
Zlatkov V; Kostova P
Akush Ginekol (Sofiia); 2004; 43 Suppl 4():43-8. PubMed ID: 15673014
[TBL] [Abstract][Full Text] [Related]
20. Family history as a predictor of uptake of cancer preventive procedures by women with a BRCA1 or BRCA2 mutation.
Metcalfe KA; Foulkes WD; Kim-Sing C; Ainsworth P; Rosen B; Armel S; Poll A; Eisen A; Gilchrist D; Chudley A; Ghadirian P; Maugard C; Lemire EG; Sun P; Narod SA
Clin Genet; 2008 May; 73(5):474-9. PubMed ID: 18341607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
